Evaluate the diagnostic value of rabbit-derived 47 kDa epitope-based antibodies in bladder cancer.
Analysis of the 47 kDa protein's performance in diagnostic contexts
Assessment of its role as a prognostic factor in bladder cancer patients
Study involving patients who have undergone trimodal therapy.
The 47 kDa protein shows strong diagnostic performance for bladder cancer.
It may serve as a significant prognostic factor for patients post-trimodal therapy.
Abstract
The 47 kDa protein demonstrates strong diagnostic performance and may be utilized as a prognostic factor in bladder cancer patients who have undergone trimodal therapy.